Catalent
CTLT
#1573
Rank
C$15.15 B
Marketcap
$83.49
Share price
0.60%
Change (1 day)
71.54%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$8.68 Billion

According to Catalent's latest financial reports the company's total liabilities are C$8.68 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30C$8.16 B10.61%
2022-06-30C$7.38 B23.16%
2021-06-30C$5.99 B2.82%
2020-06-30C$5.83 B14.07%
2019-06-30C$5.11 B12.9%
2018-06-30C$4.52 B27.65%
2017-06-30C$3.54 B11.73%
2016-06-30C$3.17 B2.17%
2015-06-30C$3.10 B-15.82%
2014-06-30C$3.69 B4.47%
2013-06-30C$3.53 B-0.53%
2012-06-30C$3.55 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$0.47 B-94.56%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.76 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.38 B 31.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$0.45 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA